Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Hear from Ruesch faculty and learn about recent research highlights.
Save the date for our next GI Cancer Patient Summit on July 15, 2023.
The Ruesch Center will hold its fourtheenth annual symposium November 17- 18, 2023.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Advances in Precision Medicine Propel Personalized GI Cancer Care
May 30th, 2023
Eileen O’Reilly, MD, and Benjamin Weinberg, MD, discuss the importance of conducting biomarker testing as the gastrointestinal cancer treatment arena continues to evolve, the need for increased gene fusion testing, and the negative effects of inadequate biomarker testing in the gastrointestinal cancer population.…
Could Microbiome Changes Explain Rise in Colon Cancer Among the Young?
May 30th, 2023
With colon cancer on the rise among younger Americans, researchers are working to figure out why. A new study suggests the microbiome — the community of microorganisms in the body — may play a role.…
New bacterial clues about why young people are getting colorectal cancer
May 30th, 2023
The type of bacteria, fungi, and viruses in colorectal cancer tumors varies significantly between younger and older patients, offering a clue toward understanding why cases are rising in people under 45, according to a study due to be presented at next week’s American Society of Clinical Oncology annual meeting.…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming special events, current clinical trials, and cutting edge research and trends in the GI cancer field.
